Meeting Coverage:

American Academy of Ophthalmology

AAO: 2017

Next-Gen Sequencing in Uveal Melanoma

Show Description +

J. William Harbour, MD, highlights the use of next-generation deep DNA sequencing in understanding the initiation and progression of uveal melanoma. Dr. Harbour notes that gene expression profiling continues to be the most accurate risk predictor for metastasis. He also discusses how clinicians can assign a specific mutation to each patient's gene expression profile, potentially leading to better understanding of the evolution of these individual mutations.

Posted: 11/17/2017

Up Next

Suprachoroidal Steroids for DME

Charles Wykoff, MD, PhD


Gene Therapy for Wet AMD

Szilárd Kiss, MD

Head-to-Head Trials

Pravin Dugel, MD

Who, What, Where, and When?

Arsham Sheybani, MD, Ike Ahmed, MD

An Update on GATT

Davinder Grover, MD

Who Should Perform MIGS?

Michael Patterson, DO

Hot Topic: Is Astigmatism Correction a Must?

George Waring IV, MD, Neel Desai, MD, Zaina Al-Mohtaseb, MD

Updates on Sjögren Syndrome

Stephen Pflugfelder, MD

Who Should Perform MIGS?

Osamah Saeedi, MD

Hot Topic: Technologies in 2018

Robert Weinstock, MD, Roger Zaldivar, MD

The Future of Cross-linking

William Trattler, MD

Should We Still Be Doing DSAEK?

Winston Chamberlain, MD, PhD

Hot Topic: Pharmaceutical Compounding

Keith Walter, MD, Nathan Radcliffe, MD, Tal Raviv, MD

Hot Topic: Successful Collaborations

Constance Okeke, MD, Greg Parkhurst, MD, John Berdahl, MD

Next-Gen Sequencing in Uveal Melanoma

J. William Harbour, MD, highlights the use of next-generation deep DNA sequencing in understanding the initiation and progression of uveal melanoma. Dr. Harbour notes that gene expression profiling continues to be the most accurate risk predictor for metastasis. He also discusses how clinicians can assign a specific mutation to each patient's gene expression profile, potentially leading to better understanding of the evolution of these individual mutations.

Posted: 11/17/2017


Please log in to leave a comment.

More From AAO: 2017 Coverage

Suprachoroidal Steroids for DME

Charles Wykoff, MD, PhD

Gene Therapy for Wet AMD

Szilárd Kiss, MD

Head-to-Head Trials

Pravin Dugel, MD